Abiomed, a publicly-traded medical device technology company that develops and manufactures temporary external and implantable mechanical circulatory support devices, has received FDA approval for a new model of its minimally invasive cardiac pump targeting the right side of the heart. This new model allows for a new approach that will make it easier for patients to walk while implanted with the device.
Click here to read the entire article.